# US 2024/0198097 A1 · Devices and methods for treating infected tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0198097 A1
- Document ID: US20240198097A1
- Status: Published application
- Kind: A1
- Application number: 18/588,877
- Filed: 2024-02-27
- Published: 2024-06-20
- Earliest claimed: 2021-08-30
- Assignees: Nanovis, LLC
- Applicants: Nanovis, LLC
- Inventors: David A. DETWILER; Alan M. KRAFT; James T. MCCARTHY; Gordon P. KISTLER
- Web page: https://patentgrep.com/patent/US20240198097A1

## CPC

- A61N 1/327: {for enhancing the absorption properties of tissue, e.g. by electroporation}
- A61F 2/30: Joints
- A61F 13/00063: {comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00)}
- A61K 31/155: Amidines ([IMAGE cpc-sch-A61K-1029.gif]), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A61K 41/0047: {Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent}
- A61M 1/90: {Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing}
- A61M 5/3286: {Needle tip design, e.g. for improved penetration}
- A61M 35/00: Devices for applying media, e.g. remedies, on the human body (devices for handling toiletry or cosmetic substances A45D; absorbent pads, e.g. swabs, A61F13/15)
- A61M 37/00: Other apparatus for introducing media into the body (for reproduction or fertilisation A61B17/425; apparatus for iontophoresis or cataphoresis A61N1/30); Percutany, i.e. introducing medicines into the body by diffusion through the skin (salt baths A61H33/04)
- A61N 1/0416: {Anode and cathode}
- A61N 1/36034: {specified by the stimulation parameters}
- A61F 2002/2821: {Bone stimulation by electromagnetic fields or electric current for enhancing ossification}
- A61M 2037/0007: {having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents}
- A61M 2205/054: with electrotherapy
- A61N 1/0412: {Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A system for treating infected tissue includes an applicator device. The applicator device has an electrode pair spaced apart and is positioned against infected tissue. An electrical power supply to generate a pulsed electric field across the electrode pair, resulting in the application of a pulsed electric field through the infected tissue. The pulsed electric field has a field strength within a range that when the pulsed electric field is applied, pores are formed in membranes of cells of the infected tissue. A method for treating infected tissue is disclosed. The method includes positioning an electrode pair against the infected tissue; applying a pulsed electric field across the electrode pair. The pulsed electric field has a field strength that when applied, pores are formed in membranes of cells of the infected tissue; and applying an antimicrobial agent into or onto the infected tissue when the pulsed electric field is applied.

## Claims

### Claim 1

A system for treating infected tissue, the system comprising:
an applicator device comprising an electrode pair spaced apart and operable to be positioned against infected tissue; and
an electrical power supply operable to apply an electric field across the electrode pair to apply a pulsed electric field through the infected tissue, wherein the pulsed electric field has a field strength within a range that when the pulsed electric field is applied, pores are formed in membranes of cells of the infected tissue.

### Claim 2 (depends on 1)

The system of claim 1, further comprising:
an antimicrobial agent operable to cross and/or integrate into the membrane of the cells when the electric field is applied.

### Claim 3 (depends on 2)

The system of claim 2 comprising:
at least one of an antibiotic, an antiseptic or an antifungal agent operable to cross or integrate into the membrane of the cells when the electric field is applied.

### Claim 4 (depends on 3)

The system of claim 3, wherein a microorganism inactivation rate of the at least one of an antibiotic, an antiseptic or an antifungal agent is greater when the pulsed electric field and antimicrobial agent are applied simultaneously than when the pulsed electric field and antimicrobial agent are applied separately.

### Claim 5 (depends on 2)

The system of claim 2, wherein the antimicrobial agent comprises a member of the biguanide family.

### Claim 6 (depends on 2)

The system of claim 2, wherein the antimicrobial agent comprises Chlorhexidine.

### Claim 7 (depends on 6)

The system of claim 6, wherein the concentration of antimicrobial agent is between 0.001 percent and 2.0 percent.

### Claim 8 (depends on 1)

The system of claim 1, further comprising:
a bridging resistor electrically connected in parallel with the electrode pair to the power supply, wherein the bridging resistor substantially matches an impedance of a pulse generator that the power supply is connected to.

### Claim 9 (depends on 1)

The system of claim 1, wherein the electrodes are spaced apart at a distance of a range of about 0.1 millimeters (mm) to 5 mm.

### Claim 10 (depends on 1)

The system of claim 1, wherein the field strength of the pulsed electric field is about 40 kilovolts per centimeter or less.

### Claim 11 (depends on 1)

The system of claim 1, wherein the pulsed electric field is comprised of a plurality of electric field pulses having a time duration of about 50 to 900 nanoseconds.

### Claim 12 (depends on 1)

The system of claim 1, wherein the applicator device comprises:
a flexible substrate operable to form a bandage for placement over the infected tissue; and
wherein the electrode pair are disposed on the substrate.

### Claim 13 (depends on 12)

The system of claim 12 wherein the electrode pair comprise a plurality of parallel electrode pairs disposed on the substrate and extend longitudinally across the substrate.

### Claim 14 (depends on 13)

The system of claim 13, wherein the substrate comprises a flexible printed circuit board that is operable to be electrically connected to the power supply.

### Claim 15 (depends on 1)

The system of claim 1, wherein the applicator device comprises:
a wand having a handle and a head, wherein the electrode pair are disposed in a distal end of the head; and
wherein, the wand is operable to be grasped by the handle by a user and the distal end of the head is operable to be pressed by the user against the infected tissue.

### Claim 16 (depends on 15)

The system of claim 15, wherein the electrode pair comprises a plurality of parallel electrode pairs spaced a substantially equal distance apart.

### Claim 17 (depends on 15)

The system of claim 15, wherein the distal end of the head comprises at least one of a convex shape, a concave shape or a flat shape.

### Claim 18 (depends on 1)

The system of claim 1, wherein the applicator device comprises a screw fastener configured to be threaded into the infected tissue.

### Claim 19 (depends on 18)

The system of claim 18, wherein the infected tissue is a human bone.

### Claim 20 (depends on 18)

The system of claim 18, wherein the applicator device comprises:
the screw fastener having threads that comprise a major diameter and a minor diameter; and
the pair of electrodes comprising a first electrode wrapped around the minor diameter and a second electrode wrapped around the major diameter.

### Claim 21 (depends on 1)

The system of claim 1, wherein the applicator device comprises:
a pin operable to be inserted into the infected tissue; and
the pair of electrodes comprising a first electrode and a second electrode wrapped around an outside surface of a shaft of the pin, the first and second electrodes being at least one of evenly spaced apart along the shaft of the pin or parallel to each other along the shaft of the pin.

### Claim 22 (depends on 21)

The system of claim 21, wherein the pin is hollow and has an inside surface, the inside surface defining a central channel, wherein the pin includes a plurality of spaced through holes disposed along the shaft of the pin, and wherein the through holes extend from the channel to the outside surface of the pin.

### Claim 23 (depends on 22)

The system of claim 22, wherein the applicator device comprises:
a syringe operable to be connected to a distal end of the pin such that the syringe is in fluid communication with the channel, the syringe is operable to deliver fluids into the channel and out through the through holes.

### Claim 24 (depends on 23)

The system of claim 23, wherein the fluids are at least one of an antimicrobial agent, antibiotic agent, an antifungal agent or an antiseptic agent.

### Claim 25 (depends on 1)

The system of claim 1, wherein the applicator device comprises:
an implant that is operable to be inserted into the infected tissue; and
wherein the electrode pair are disposed on an outer surface of the implant.

### Claim 26 (depends on 25)

The system of claim 25, wherein the electrode pair comprise a plurality of electrode pairs disposed on the outer surface of the implant.

### Claim 27 (depends on 25)

The system of claim 25, wherein the tissue is human bone.

### Claim 28 (depends on 25)

The system of claim 25, wherein the implant is one of a plate, a knee implant, a shoulder implant, an elbow implant, an ankle implant, a spine interbody implant or a hip stem.

### Claim 29 (depends on 1)

The system of claim 1, wherein the applicator device comprise a negative pressure wound therapy device.

### Claim 30

A system for treating infected tissue, the system comprising:
an applicator device comprising an electrode pair spaced apart and operable to be positioned against the infected tissue; and
an electrical power supply operable to generate an electric field having a field strength of 40 kV/cm or less across the electrode pair to apply a pulsed electric field being comprised of a plurality of electric field pulses having a time duration of about 50 to 900 nanoseconds through the infected tissue, wherein the pulsed electric field has a field strength within a range that when the pulsed electric field is applied, pores are formed in membranes of cells of the infected tissue; and
an antimicrobial agent operable to cross or integrate into the membrane of the cells when the pulsed electric field is applied.

### Claim 31 (depends on 30)

The system of claim 30, comprising:
at least one of an antibiotic, an antiseptic or an antifungal agent operable to cross or integrate into the membrane of the cells when the pulsed electric field is applied;
wherein a microorganism inactivation rate of the at least one of an antibiotic, an antiseptic or an antifungal agent is greater when the pulsed electric field and antimicrobial agent are applied simultaneously than when the pulsed electric field and antimicrobial agent are applied separately.

### Claim 32 (depends on 30)

The system of claim 30, wherein the pulsed electric field has an electric field strength of about 30 kV/cm or less.

### Claim 33 (depends on 30)

The system of claim 30, wherein the antimicrobial agent comprises a member of the biguanide family.

### Claim 34 (depends on 30)

The system of claim 30, wherein the antimicrobial agent comprises Chlorhexidine.

### Claim 35 (depends on 30)

The system of claim 30, wherein the concentration of antimicrobial agent is between 0.001 percent and 2.0 percent.

### Claim 36 (depends on 30)

The system of claim 30, wherein the applicator device comprises:
a flexible substrate operable to form a bandage for placement over the infected tissue; and
wherein the electrode pair are disposed on the substrate.

### Claim 37 (depends on 36)

The system of claim 36 wherein the electrode pair comprise a plurality of parallel electrode pairs disposed on the substrate and extend longitudinally across the substrate.

### Claim 38 (depends on 30)

The system of claim 30, wherein the applicator device comprises:
a wand having a handle and a head;
wherein the electrode pair are disposed in a distal end of the head; and
wherein, the wand is operable to be grasped by the handle by a user and the distal end of the head is configured to be pressed by the user against the infected tissue.

### Claim 39 (depends on 30)

The system of claim 30, wherein the applicator device comprises:
a screw operable to be threaded into the infected tissue, the screw having threads that define a major diameter and a minor diameter; and wherein the pair of electrodes comprise a first electrode wrapped around the minor diameter and a second electrode wrapped around the major diameter.

### Claim 40 (depends on 30)

The system of claim 30, wherein the applicator device comprises:
a pin operable to be inserted into the infected tissue; and
the pair of electrodes comprising a first electrode and a second electrode wrapped around an outside surface of the pin, the first and second thread wires being evenly spaced.

### Claim 41 (depends on 40)

The system of claim 40, wherein the pin is hollow and has an inside surface, wherein the inside surface defines a central channel, the pin includes a plurality of spaced through holes disposed along a length of the pin, the through holes extend from the channel to the outside surface of the pin; and
a syringe connected to a distal end of the pin such that the syringe is in fluid communication with the channel, the syringe operable to deliver fluids into the channel and out from the through holes.

### Claim 42 (depends on 30)

The system of claim 30, wherein the applicator device comprises:
an implant that is configured for insertion into the infected tissue; and
wherein the electrode pair are disposed on an outer surface of implant.

### Claim 43 (depends on 42)

The system of claim 42, wherein the electrode pair comprise a plurality of electrode pairs disposed on the outer surface of the implant.

### Claim 44 (depends on 42)

The system of claim 42, wherein the implant is at least one of a plate, a knee implant, a shoulder implant, an elbow implant, and ankle implant, a spine interbody implant or a hip stem.

### Claim 45 (depends on 30)

The system of claim 30, wherein the applicator device comprise a negative pressure wound therapy device.

### Claim 46

A method for treating infected tissue, the method comprising:
positioning an electrode pair against the infected tissue;
applying a pulsed electric field across the electrode pair generated from a power supply through the infected tissue, wherein the pulsed electric field has a field strength within a range that when the pulsed electric field is applied, pores are formed in membranes of cells of the infected tissue; and
applying an antimicrobial agent into or onto the infected tissue when the pulsed electric field is applied, wherein the antimicrobial agent crosses or integrates into the membrane of the cells when the pulsed electric field is applied.

### Claim 47 (depends on 46)

The method of claim 46, comprising:
applying at least one of an antibiotic, an antiseptic or an antifungal agent into or onto the infected tissue, the at least one of an antibiotic, an antiseptic or an antifungal agent crosses or integrates into the membrane of the cells when the pulsed electric field is applied.

### Claim 48 (depends on 47)

The method of claim 47, wherein a microorganism inactivation rate of the at least one of an antibiotic, an antiseptic or an antifungal agent is greater when the pulsed electric field and antimicrobial agent are applied simultaneously than when the pulsed electric field and antimicrobial agent are applied separately.

### Claim 49 (depends on 46)

The method of claim 46, wherein the antimicrobial agent comprises a member of the biguanide family.

### Claim 50 (depends on 46)

The method of claim 46, comprising:
spacing the electrode pair apart a distance within a range of 0.1 millimeters (mm) to 5 mm.

### Claim 51 (depends on 46)

The method of claim 46, wherein the field strength is about 40 kilovolts per centimeter or less.

### Claim 52 (depends on 51)

The method of claim 51, wherein the field strength is about 20 kilovolts per centimeter or less.

### Claim 53 (depends on 51)

The method of claim 51, wherein the field strength is about 18 kilovolts per centimeter or less.

### Claim 54 (depends on 46)

The method of claim 46, comprising:
applying the pulsed electric field as a plurality of electric field pulses having a time duration of about between 50 to 900 nanoseconds.

### Claim 55 (depends on 46)

The method of claim 46, wherein the electrode pair is disposed within an applicator device.

### Claim 56 (depends on 55)

The method of claim 55, wherein the applicator device comprises at least one of a wand, a pin, a screw, a bandage, a negative pressure wound therapy device or an implant.
